Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Baxter
Accenture
Covington
Teva
Colorcon
Citi
Fuji
Julphar

Generated: December 9, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050533

« Back to Dashboard

NDA 050533 describes VIBRA-TABS, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the VIBRA-TABS profile page.

The generic ingredient in VIBRA-TABS is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Ninety-seven suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for 050533
Tradename:VIBRA-TABS
Applicant:Pfizer
Ingredient:doxycycline hyclate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrengthEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
Teva
Baxter
Fish and Richardson
Chinese Patent Office
Fuji
Accenture
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.